Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
Industrial Microbiology
... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$15.4 ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the end of the analysis period. ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Microtomes
... 6.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth in ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach ... Read More
-
Breath Analyzers
... CAGR of 15.4% over the analysis period 2024-2030. Fuel Cells, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the analysis ... Read More
-
First Aid Kits
... at a CAGR of 6.2% over the analysis period 2024-2030. Common Type Kit, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$189.1 Million by the end ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Urinalysis
... 5.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
-
Service Laboratories
... CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$31.3 Billion While China is Forecast to Grow at 4.0% CAGR The Service Laboratories market in the U.S. is estimated at ... Read More
-
Veterinary Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the analysis period. ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by ... Read More
-
Automated Immunoassay Analyzers
... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Oncology Companion Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
DNA Probes-Based Diagnostics
... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end of ... Read More
-
Diabetes Diagnostics
... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
2025 Global Fully Automated Coagulation Analyzer Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
Microbial Identification Market Report by Products and Services (Instruments and Software, Consumables, Services), Technology (Mass Spectrometry, PCR, Flow Cytometry, Microscopy, and Others), Method (Phenotypic Methods, Genotypic Methods, Proteomics-Based Methods), Application (Diagnostics, Food and Beverage Testing, Pharmaceuticals, Cosmetics and Personal Care Products Testing, and Others), and Region 2025-2033
... There are several factors that are driving the market, which include the increasing focus on food safety testing, expansion of the pharmaceutical and biotechnology industries, and rising need for environmental monitoring in water treatment and ... Read More
-
Point of Care Molecular Diagnostics Market Report by Product and Service (Assays and Kits, Instruments and Analyzers, Software and Services), Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Others), End User (Physicians’ Offices, Hospitals and ICUs, Research Institutes, and Others), and Region 2025-2033
... 8.78% during 2025-2033. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth. Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and ... Read More
Research Assistance
